Kolexia
Tardy Magalie Oncologie médicale
Tardy Magalie
Oncologie médicale
Centre Antoine Lacassagne
Nice, France
58 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Carcinomes Carcinome épidermoïde Carcinome épidermoïde de la tête et du cou Tumeurs de la tête et du cou Gliome Métastase tumorale Maladie de Hodgkin

Collaborateurs

Voir plus
Kogay Maria
Kogay Maria
Centre Antoine Lacassagne, Nice, France
Pujalte Martin Marc
Pujalte Martin Marc
Centre Antoine Lacassagne, Nice, France
Cassuto Ophelie
Cassuto Ophelie
Centre Antoine Lacassagne, Nice, France
Montagne Lucile
Montagne Lucile
Hp A. Tzanck Mougins Sophia Antipolis, Mougins, France

Industries

Voir plus
B3TSI
32 collaboration(s)
Dernière en 2022
A+A
12 collaboration(s)
Dernière en 2023
IQVIA
12 collaboration(s)
Dernière en 2022
Astellas
7 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
MegaMOST - A Multicenter, Open-label, Biology Driven, Phase II Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations /Characteristics in Advanced / Metastatic Tumors.
Essai Clinique (Centre Léon-Bérard)   16 novembre 2023
Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥ 6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: a retrospective study.
BMC cancer   14 juillet 2023
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study.
Blood advances   01 novembre 2021
OUTCOMES AFTER FIRST-LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDY
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   17 juin 2021
050 | OUTCOMES AFTER FIRST-LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDY
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   09 juin 2021
Adaptation of chemotherapy to the decline tumor markers in patients with poor prognosis nonseminomatous germ cell tumors:Real-world French experience.
2021 Genitourinary Cancers Symposium   02 mars 2021
R-CHOP14 As a Standard of Care in Primary Mediastinal B Cell Lymphoma: A 10-YEARS Experience of Lysa Centers
Blood   05 novembre 2020
Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group.
Clinical genitourinary cancer   05 décembre 2019
Large retrospective study of lenalidome-dexamethasone (Rd) in patients older than 80 with multiple myeloma (MM): Is less more?
2018 ASCO Annual Meeting I   01 juin 2018
Microsatellite instability associated with durable complete response to PD-L1 inhibitor in head and neck squamous cell carcinoma.
Oral oncology   07 avril 2018